Archives of Gynecology and Obstetrics

, Volume 298, Issue 4, pp 781–787 | Cite as

Recurrent pregnancy loss and future risk of female malignancies

  • Ron Charach
  • Eyal Sheiner
  • Ofer Beharier
  • Ruslan Sergienko
  • Roy KessousEmail author
General Gynecology



To investigate whether patients with a history of recurrent pregnancy loss (RPL) have an increased risk for future female malignancies.


A retrospective population-based study compared the incidence of long-term female malignancies in a cohort of women with and without a history of RPL (2 or more consecutive pregnancy losses). Deliveries occurred between the years 1988 and 2013, with a mean follow-up duration of 12 years. Women with known malignancies before the index pregnancy were excluded from the analysis. Female malignancies were divided according to specific type including ovary, breast, uterine and uterine cervix. Kaplan–Meier survival curve was used to estimate the cumulative incidence of malignancies. Cox proportional hazards model was used to determine the adjusted hazard ratios (HR) for female malignancy after controlling for confounders.


During the study period, 106,265 patients met the inclusion criteria; 6.6% (n = 7052) of patients had a diagnosis of RPL. During the follow-up period, patients with RPL had a significantly increased risk of being diagnosed with female malignancies as a group, while individually there was an increased risk of breast and uterine cervix cancer. Using a Kaplan–Meier survival curve, patients with a history of RPL had a significantly higher cumulative incidence of female malignancies. Using a Cox proportional hazards model, adjusted for confounders such as smoking, parity, and diabetes mellitus, a history of RPL remained independently associated with female malignancies (adjusted HR 1.4; P = 0.003).


RPL is independently associated with long-term female malignancies. Patients with a history of RPL may benefit from counseling and screening for breast and uterine cervix cancer in particular.


Recurrent pregnancy loss Long-term risk Ovarian cancer Uterine cancer Breast cancer Cervical cancer 


Author contributions

RC manuscript writing, protocol development, project administration. ES protocol development, manuscript editing. OB manuscript editing, project administration. RS data analysis. RK protocol development, manuscript editing.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval with regard to research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

No humans involved in this article.


  1. 1.
    Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N et al (2012) Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 125(11):1367–1380CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kessous R, Walfisch A, Meirovitz M, Davidson E, Sergienko R, Sheiner E (2016) Preterm delivery and future maternal risk of female malignancies. Arch Gynecol Obstet 295:205–210CrossRefPubMedGoogle Scholar
  3. 3.
    Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E (2016) Prepregnancy obesity: a risk factor for future development of ovarian and breast cancer. Eur J Cancer Prev 26:151–155CrossRefGoogle Scholar
  4. 4.
    Beral V (1985) Long term effects of childbearing on health. J Epidemiol Community Health 39(4):343–346CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mangos GJ, Spaan JJ, Pirabhahar S, Brown MA (2012) Markers of cardiovascular disease risk after hypertension in pregnancy. J Hypertens 30(2):351–358CrossRefPubMedGoogle Scholar
  6. 6.
    Pariente G, Shoham-Vardi I, Kessous R, Sherf M, Sheiner E (2014) Placental abruption as a significant risk factor for long-term cardiovascular mortality in a follow-up period of more than a decade. Paediatr Perinat Epidemiol 28(1):32–38CrossRefPubMedGoogle Scholar
  7. 7.
    Shah BR, Retnakaran R, Booth GL (2008) Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 31(8):1668–1669CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Smith GC, Pell JP, Walsh D (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357(9273):2002–2006CrossRefPubMedGoogle Scholar
  9. 9.
    Purdie DM (2003) Epidemiology of endometrial cancer. Rev Gynaecol Pract 3(4):217–220CrossRefGoogle Scholar
  10. 10.
    Huang Z, Beeghly-Fadiel A, Gao YT, Zheng Y, Dai Q, Lu W et al (2013) Associations of reproductive time events and intervals with breast cancer risk: a report from the Shanghai Breast Cancer Study. Int J Cancer 135:186–195CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261):624–628CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomark Prev 14(1):98–107Google Scholar
  13. 13.
    Ho SM (2003) Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 1:73CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Desantis C, Ma J, Bryan L, Jemal A (2013) Breast cancer statistics, 2013. CA Cancer J Clin 34:52–62Google Scholar
  15. 15.
    Permuth-Wey J, Besharat A, Sellers TA (2014) Epidemiology of ovarian cancer: an update. In: Farghaly SA (ed) Advances in diagnosis and management of ovarian cancer. Springer, Boston, MA, PA, pp 1–21Google Scholar
  16. 16.
    Santucci-Pereira J, George C, Armiss D, Russo IH, Vanegas JE, Sheriff F et al (2013) Mimicking pregnancy as a strategy for breast cancer prevention. Breast Cancer Manag 2(4):283–294CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2006) Incidence of ovarian cancer of grand multiparous women—a population-based study in Finland. Gynecol Oncol 103(1):207–211CrossRefPubMedGoogle Scholar
  18. 18.
    Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2002) Grand multiparity and incidence of endometrial cancer: a population-based study in Finland. Int J Cancer 98(6):912–915CrossRefPubMedGoogle Scholar
  19. 19.
    Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS et al (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet 359(9312):1093–1101CrossRefPubMedGoogle Scholar
  20. 20.
    Autier P, Coibion M, Huet F, Grivegnee AR (1996) Transformation zone location and intraepithelial neoplasia of the cervix uteri. Br J Cancer 74(3):488–490CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E et al (1989) Parity as a risk factor for cervical cancer. Am J Epidemiol 130(3):486–496CrossRefPubMedGoogle Scholar
  22. 22.
    Potdar N, Konje JC (2005) The endocrinological basis of recurrent miscarriages. Curr Opin Obstet Gynecol 17(4):424–428CrossRefPubMedGoogle Scholar
  23. 23.
    van den Boogaard E, Kaandorp SP, Franssen MT, Mol BW, Leschot NJ, Wouters CH et al (2010) Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? Hum Reprod 25(6):1411–1414CrossRefPubMedGoogle Scholar
  24. 24.
    American College of Obstetricians and Gynecologists (2002) ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 78(2):179–190CrossRefGoogle Scholar
  25. 25.
    Kolte AM, Bernardi LA, Christiansen OB, Quenby S, Farquharson RG, Goddijn M et al (2015) Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod 30(3):495–498CrossRefPubMedGoogle Scholar
  26. 26.
    Dai D, Wolf DM, Litman ES, White MJ, Leslie KK (2002) Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 62(3):881–886PubMedGoogle Scholar
  27. 27.
    Brisken C (2014) Reply to Is progesterone a neutral or protective factor for breast cancer? Nat Rev Cancer 14(2):146-c2 (Epub 2014 Jan 20) CrossRefGoogle Scholar
  28. 28.
    Santamaria X, Taylor H (2014) MicroRNA and gynecological reproductive diseases. Fertil Steril 101(6):1545–1551CrossRefPubMedGoogle Scholar
  29. 29.
    Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590–610CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Beral V, Bull D, Doll R, Peto R, Reeves G, Collaborative Group on Hormonal Factors in Breast Cancer (2004) Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 363(9414):1007–1016CrossRefPubMedGoogle Scholar
  31. 31.
    Brinton LA, Hoover R, Fraumeni JF Jr (1983) Reproductive factors in the aetiology of breast cancer. Br J Cancer 47(6):757–762CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Dick ML, Siskind V, Purdie DM, Green AC (2009) Australian Cancer Study Group (Ovarian Cancer), Australian Ovarian Cancer Study Group. Incomplete pregnancy and risk of ovarian cancer: results from two Australian case–control studies and systematic review. Cancer Causes Control 20(9):1571–1585CrossRefPubMedGoogle Scholar
  33. 33.
    Braem MG, Onland-Moret NC, Schouten LJ, Kruitwagen RF, Lukanova A, Allen NE et al (2012) Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition. PLoS One 7(5):e37141CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jonsson L, Eriksen PS et al (2000) Risk factors among young women with endometrial cancer: a Danish case–control study. Am J Obstet Gynecol 182(1 Pt 1):23–29CrossRefPubMedGoogle Scholar
  35. 35.
    Xu WH, Xiang YB, Ruan ZX, Zheng W, Cheng JR, Dai Q et al (2004) Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case–control study in urban Shanghai. Int J Cancer 108(4):613–619CrossRefPubMedGoogle Scholar
  36. 36.
    McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR (1996) Reproductive factors and risk of endometrial cancer. The Iowa Women’s Health Study. Am J Epidemiol 143(12):1195–1202CrossRefPubMedGoogle Scholar
  37. 37.
    Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Holcberg G, Sheiner E (2014) Recurrent pregnancy loss: a risk factor for long-term maternal atherosclerotic morbidity? Am J Obstet Gynecol 211:414-e1CrossRefGoogle Scholar
  38. 38.
    Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E (2013) An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart 99(15):1118–1121CrossRefPubMedGoogle Scholar
  39. 39.
    Lowe KA, Chia VM, Taylor A, O’Malley C, Kelsh M, Mohamed M et al (2013) An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 130(1):107–114CrossRefPubMedGoogle Scholar
  40. 40.
    Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (1975–2015) SEER Cancer Statistics Review, National Cancer Institute. Bethesda, MD, based on November 2017 SEER data submission, posted to the SEER web site, April 2018
  41. 41.
    Brigham SA, Conlon C, Farquharson RG (1999) A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 14(11):2868–2871CrossRefPubMedGoogle Scholar
  42. 42.
    Lund M, Kamper-Jorgensen M, Nielsen HS, Lidegaard O, Andersen AM, Christiansen OB (2012) Prognosis for live birth in women with recurrent miscarriage: What is the best measure of success? Obstet Gynecol. 119(1):37–43. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical CenterBen-Gurion University of the NegevBeer-ShevaIsrael
  2. 2.Department of Public HealthBen-Gurion University of the NegevBeer-ShevaIsrael
  3. 3.Division of Gynecologic Oncology, Segal Cancer Center, SMBD Jewish General HospitalMcGill UniversityMontrealCanada

Personalised recommendations